Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_assertion type Assertion NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_head.
- NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_assertion description "[Not only was the distribution of patients with T-ALL different over the MRD-based risk groups, the prognostic value of MRD levels at TP1 and TP2 was higher in T-ALL (larger RFS gradient), and consistently higher RFS rates were found for MRD-negative T-ALL patients at the first 5 follow-up time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_provenance.
- NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_assertion evidence source_evidence_literature NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_provenance.
- NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_assertion SIO_000772 12036866 NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_provenance.
- NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_assertion wasDerivedFrom befree-20140225 NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_provenance.
- NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_assertion wasGeneratedBy ECO_0000203 NP497353.RAnBJza7rPIMTL3AjK_2HKVgheXu84R-YhEzWNNL1Sx1I130_provenance.